調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022

治験管理システムの世界市場予測（～2022年）

◆タイトル：Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022
◆商品コード：HIT-1686
◆調査・発行会社：MarketsandMarkets
◆発行日：2018年1月18日
◆ページ数：266
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名利用）USD5,650 ⇒換算￥615,850見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥724,850見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥888,350見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、治験管理システムの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、需要先別分析、提供方式別分析、種類別分析、構成要素別分析、治験管理システムの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The clinical trial management system (CTMS) market is projected to grow at a CAGR of 12.6% during the forecast period”The global CTMS market is projected to reach USD 1,065.6 million by 2022 from USD 590.0 million in 2017, at a CAGR of 12.6%. The major factors driving the growth of the CTMS market include the increasing partnerships between biopharma companies and CROs, rising number of ongoing clinical trials, rising government funding & grants to support clinical trials, availability of advanced CTMS solutions, and growing customer base for CTMS solutions. However, the major market restraints are limited awareness among researchers about the advantages of CTMS solutions and budget constraints faced by the emerging countries.

“The cloud-based CTMS segment is expected to grow at the highest rate during the forecast period”
On the basis of delivery mode, the global CTMS market is segmented into web-based (on-demand), licensed enterprise (on premise), and cloud-based (SaaS) segments. The cloud-based (SaaS) segment is estimated to witness the highest growth during the forecast period, primarily due to the rising adoption of cloud-based solutions in medical research studies owing to various benefits offered by them such as low cost, high security, privacy, and easy accessibility from any device.

“Software segment accounted for the largest share of the CTMS market by component”
On the basis of component, the CTMS market is segmented into software and services. The software segment is expected to have the largest share of the market. This is mainly attributed to the fierce competition in the pharmaceutical industry to introduce cost-effective novel drugs in the market, increased adoption of CTMS due to advantages provided by the same among various end users, and increasing number of clinical trials.

“The APAC market is expected to grow at the highest CAGR during the forecast period”
Geographically, the CTMS market is segmented into North America, Europe, Asia Pacific (APAC), and the rest of the world. The APAC market is expected to register the highest growth rate during the forecast period. Increasing government funding to support clinical trials, the presence of less stringent regulatory guidelines as compared to developed nations, a large patient base, faster rate of patient recruitment for clinical trials than mature nations, low operating costs for conducting clinical trials, shortage of trial volunteers in Europe and North America, and the growing number of pharmaceutical companies and CROs are fueling the growth of the APAC CTMS market.

Breakdown of supply-side primary interviews:
• By Company Type – Tier 1 – 25%, Tier 2 – 30% and Tier 3 – 45%
• By Designation – C-level – 26%, Director level – 30%, Others – 44%
• By Region – North America – 34%, Europe – 26%, APAC – 23%, RoW – 17%

The major players in the market included are Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), and IBM (US).

Research Coverage

This report studies the CTMS market based on type, delivery mode, component, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Reasons to Buy the Report:

This report focuses on various levels of analysis—industry trends, market ranking of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the CTMS market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKETS SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED
1.5 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION
2.2.1 TOP-DOWN APPROACH
2.2.2 BOTTOM-UP APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 CTMS: MARKET OVERVIEW (2017–2022)
4.2 GLOBAL CTMS MARKET, BY COMPONENT, 2017 VS. 2022
4.3 GLOBAL CTMS MARKET, BY TYPE, 2017 VS. 2022
4.4 GLOBAL CTMS MARKET, BY END-USER AND MODE OF DELIVERY (2017)
4.5 CTMS MARKET BY COUNTRY, 2017
5 MARKET OVERVIEW
5.1 DRIVERS
5.2 RESTRAINTS
5.3 OPPORTUNITIES
5.4 CHALLENGES
5.5 KEY INDUSTRY TRENDS
 
6 CTMS MARKET, BY TYPE
6.1 INTRODUCTION
6.2 ENTERPRISE CTMS
6.3 SITE CTMS
7 CTMS MARKET, BY DELIVERY MODE
7.1 INTRODUCTION
7.2 WEB-BASED (HOSTED) CTMS
7.3 LICENSED ENTERPRISE (ON PREMISE) CTMS
7.4 CLOUD-BASED (SAAS) CTMS
8 CTMS MARKET, BY COMPONENT
8.1 INTRODUCTION
8.2 SOFTWARES
8.3 SERVICES
9 CTMS MARKET, BY END USER
9.1 INTRODUCTION
9.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
9.2.1 LARGE PHARMACEUTICAL COMPANIES
9.2.2 MID-SMALL PHARMACEUTICAL COMPANIES
9.3 CONTRACT RESEARCH ORGANIZATIONS
9.4 MEDICAL DEVICE COMPANIES
9.5 OTHER END USERS
10 CTMS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 UK
10.3.3 FRANCE
10.3.4 REST OF EUROPE (ROE)
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.2 JAPAN
10.4.3 INDIA
10.4.4 REST OF ASIA PACIFIC
10.5 REST OF THE WORLD (ROW)
 
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 CTMS MARKET SHARE ANALYSIS, BY KEY PLAYERS (2016)
11.3 COMPETITIVE SCENARIO AND TRENDS
11.3.1 PRODUCT LAUNCHES AND ENHANCEMENTS (2014–2017)
11.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2014–2017)
11.3.3 MARKET EXPANSIONS (2014–2017)
11.3.4 MERGERS AND ACQUISITIONS (2014–2017)
*Top 15 companies analyzed for this studies are – Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), IBM (US), DATATRAK (US), Veeva Systems (US), DSG (US), MasterControl (US), ERT (US), Forte Research Systems (US), MedNet Solutions (US), ArisGlobal (US), and DZS Software Solutions (US).
12 COMPANY PROFILES
(Introduction, Products & Services, Financial Snapshots, Developments, MnM View)*
12.1 ORACLE
12.2 MEDIDATA SOLUTIONS
12.3 PAREXEL
12.4 BIOCLINICA
12.5 BIO-OPTRONICS
12.6 IBM
12.7 DATATRAK
12.8 VEEVA SYSTEMS
12.9 DSG
12.10 MASTERCONTROL
12.11 ERT
12.12 FORTE RESEARCH SYSTEMS
12.13 MEDNET SOLUTIONS
12.14 ARISGLOBAL
12.15 DZS SOFTWARE SOLUTIONS
*Details on MarketsandMarkets view, Introduction, Product & Services, New Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHORS DETAILS

LIST OF TABLES

TABLE – 1 LIST OF PARTNERSHIPS BETWEEN BIOPHARMA COMPANIES AND CROS
TABLE – 2 GLOBAL CTMS MARKET, BY TYPE, 2017–2022 (USD MILLION)
TABLE – 3 CTMS MARKET FOR ENTERPRISE CTMS, BY REGION, 2017–2022 (USD MILLION)
TABLE – 4 CTMS MARKET FOR SITE CTMS, BY REGION, 2017–2022 (USD MILLION)
TABLE – 5 GLOBAL CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
TABLE – 6 WEB-BASED (ON-DEMAND) CTMS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE – 7 LICENSED ENTERPRISE (ON-PREMISE) CTMS MARKET, BY REGION,
2015–2022 (USD MILLION)
TABLE – 8 CLOUD-BASED (SAAS) CTMS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE – 9 GLOBAL CTMS MARKET, BY COMPONENT, 2017–2022 (USD MILLION)
TABLE –10 CTMS MARKET FOR SOFTWARE BY REGION, 2017–2022 (USD MILLION)
TABLE – 11 CTMS MARKET FOR SERVICES BY REGION, 2017–2022 (USD MILLION)
TABLE – 12 GLOBAL CTMS MARKET, BY END USER, 2017–2022 (USD MILLION)
TABLE – 13 CTMS MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
BY REGION, 2017–2022 (USD MILLION)
TABLE – 14 CTMS MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
BY TYPE, 2017–2022 (USD MILLION)
TABLE – 15 CTMS MARKET FOR LARGE PHARMACEUTICAL COMPANIES BY REGION,
2017–2022 (USD MILLION)
TABLE – 16 CTMS MARKET FOR SMALL-MID SIZED PHARAMCEUTICAL COMPANIES BY REGION, 2017–2022 (USD MILLION)
TABLE – 17 STRATEGIC ALLIANCES BETWEEN CROS AND PHARMA COMPANIES (2011–2015)
TABLE – 18 CTMS MARKET FOR CRO BY REGION, 2017–2022 (USD MILLION)
TABLE – 19 CTMS MARKET FOR MEDICAL DEVICE COMPANIES BY REGION,
2017–2022 (USD MILLION)
TABLE – 20 CTMS MARKET FOR OTHER END USERS BY REGION, 2017–2022 (USD MILLION)
TABLE – 21 CTMS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE – 22 NORTH AMERICA: CTMS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE – 23 NORTH AMERICA: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE – 24 NORTH AMERICA: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE – 25 NORTH AMERICA: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
TABLE – 26 NORTH AMERICA: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE – 27 NORTH AMERICA: PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE – 28 US: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE – 29 US: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE – 30 US: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
TABLE – 31 US: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE – 32 CANADA: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE – 33 CANADA: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE – 34 CANADA: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
TABLE – 35 CANADA: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE – 36 EUROPE: CTMS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE – 37 EUROPE : CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE – 38 EUROPE : CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE – 39 EUROPE : CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
TABLE – 40 EUROPE : CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE – 41 EUROPE : PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET,
BY TYPE, 2015–2022 (USD MILLION)
TABLE – 42 GERMANY: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE – 43 GERMANY: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE – 44 GERMANY: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
TABLE – 45 GERMANY: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE – 46 UK: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE – 47 UK: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE – 48 UK: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
TABLE – 49 UK: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE – 50 FRANCE: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE – 51 FRANCE: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE – 52 FRANCE : CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
TABLE – 53 FRANCE : CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE – 54 ROE: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE – 55 ROE: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE – 56 ROE: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
TABLE – 57 ROE: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE – 58 APAC: CTMS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE – 59 APAC: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE – 60 APAC: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE – 61 APAC: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
TABLE – 62 APAC: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE – 63 APAC: PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE – 64 CHINA: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE – 65 CHINA: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE – 66 CHINA: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
TABLE – 67 CHINA: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE – 68 JAPAN: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE – 69 JAPAN: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE – 70 JAPAN: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
TABLE – 71 JAPAN: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE – 72 INDIA: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE – 73 INDIA: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE – 74 INDIA: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
TABLE – 75 INDIA: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE – 76 ROAPAC: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION))
TABLE – 77 ROAPAC: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE – 78 ROAPAC: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION))
TABLE – 79 ROAPAC: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE – 80 ROW: CTMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE – 81 ROW: CTMS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE – 82 ROW: CTMS MARKET, BY DELIVERY MODE, 2015–2022 (USD MILLION)
TABLE – 83 ROW: CTMS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE – 84 ROW: PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE – 85 PRODUCT LAUNCHES AND ENHANCEMENTS (2014–2017)
TABLE – 86 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2014–2017)
TABLE – 87 MARKET EXPANSIONS (2014–2017)
TABLE – 88 MERGERS AND ACQUISITIONS (2014–2017)


LIST OF FIGURES

FIGURE-1 RESEARCH DESIGN
FIGURE-2 BREAKDOWN OF PRIMARIES
FIGURE-3 ENTERPRISE CTMS SEGMENT TO HOLD THE LARGEST SHARE OF THE CTMS MARKET IN 2017
FIGURE-4 SOFTWARE SEGMENT TO HOLD THE LARGEST SHARE IN THE CTMS MARKET DURING 2017–2022
FIGURE-5 WEB-BASED CTMS SEGMENT TO HOLD THE LARGEST SHARE IN THE CTMS MARKET DURING THE FORECAST PERIOD
FIGURE-6 CTMS MARKET, BY END USER, 2017 VS. 2022
FIGURE-7 NORTH AMERICA TO DOMINATE THE GLOBAL CTMS MARKET DURING THE FORECAST PERIOD
FIGURE-8 RISING NUMBER OF CLINICAL TRIALS TO DRIVE THE GROWTH OF THE MARKET
(2017–2022)
FIGURE-9 SOFTWARE PLATFORMS TO DOMINATE THE GLOBAL CTMS MARKET TILL 2022
FIGURE-10 ENTERPRISE BASED CTMS PLATFORMS TO DOMINATE THE GLOBAL CTMS MARKET TILL 2022
FIGURE-11 WEB-BASED CTMS AND PHARMACEUTICAL COMPANIES TO DOMINATE THE CTMS MARKET IN 2017
FIGURE-12 CHINA TO BE THE FASTEST-GROWING MARKETS FOR CTMS DURING THE FORECAST PERIOD
FIGURE-13 MARKET DYNAMICS: DRIVER, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
FIGURE-14 GLOBAL INCREASE IN THE NUMBER OF CLINICAL TRIALS, 2002–2017
FIGURE-15 GLOBAL CTMS MARKET SHARE, BY TYPE, 2017 VS. 2022
FIGURE-16 ENTERPRISE CTMS MARKET SHARE, BY GEOGRAPHY (2017)
FIGURE-17 SITE CTMS MARKET SHARE, BY GEOGRAPHY (2017)
FIGURE-18 GLOBAL CTMS MARKET, BY MODE OF DELIVERY (2017 VS 2022)
FIGURE-19 WEB-BASED (ON-DEMAND) SEGMENT TO DOMINATE THE GLOBAL CTMS MARKET IN 2017
FIGURE-20 WEB-BASED (ON DEMAND) CTMS MARKET SHARE, BY REGION(2017)
FIGURE-21 LICENSED ENTERPRISE (ON-PREMISE) CTMS MARKET SHARE, BY REGION (2017)
FIGURE-22 CLOUD-BASED (SAAS) CTMS MARKET SHARE, BY REGION (2017)
FIGURE-23 SOFTWARE SEGMENT TO DOMINATE THE GLOBAL CTMS SOLUTIONS MARKET IN 2017
FIGURE-24 SOFTWARE MARKET SHARE, BY GEOGRAPHY (2017)
FIGURE-25 SERVICES MARKET SHARE, BY GEOGRAPHY (2017)
FIGURE-26 GLOBAL CTMS MARKET, BY END USER, 2017
FIGURE-27 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES SEGMENT TO DOMINATE THE GLOBAL CTMS MARKET IN 2017
FIGURE-28 R&D EXPENDITURE OF MAJOR PHARMACEUTICAL COMPANIES,
2015 VS. 2016 (USD MILLION)
FIGURE-29 PHARMACEUTICAL COMPANIES MARKET SHARE, BY GEOGRAPHY (2017)
FIGURE-30 LARGE PHARMACEUTICAL COMPANIES MARKET SHARE, BY GEOGRAPHY (2017)
FIGURE-31 MID-SMALL PHARAMCEUTICAL COMPANIES MARKET SHARE, BY GEOGRAPHY (2017)
FIGURE-32 CRO SERVICES COVER THE ENTIRE DRUG DEVELOPMENT SPECTRUM
FIGURE-33 CRO MARKET SHARE, BY GEOGRAPHY (2017)
FIGURE-34 MEDICAL DEVICE COMPANIES MARKET SHARE, BY GEOGRAPHY (2017)
FIGURE-35 OTHER END USERS MARKET SHARE, BY GEOGRAPHY (2017)
FIGURE-36 CTMS MARKET BY REGION (2017 VS 2022)
FIGURE-37 TOTAL NUMBER OF ONGOING CLINICAL TRIALS, BY REGION (DECEMBER 2017)
FIGURE-38 EUROPE: PHARMACEUTICAL R&D EXPENDITURE, BY COUNTRY, 2015 (USD MILLION)
FIGURE-39 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE CTMS MARKET,
2014-2017
FIGURE-40 CTMS MARKET SHARE ANALYSIS, 2016
FIGURE-41 ORACLE : COMPANY SNAPSHOT
FIGURE-42 MEDIDATA SOLUTIONS: COMPANY SNAPSHOT
FIGURE-43 PAREXEL : COMPANY SNAPSHOT
FIGURE-44 IBM : COMPANY SNAPSHOT
FIGURE-45 DATATRAK : COMPANY SNAPSHOT
FIGURE-46 VEEVA SYSTEMS : COMPANY SNAPSHOT


【レポートのキーワード】

治験管理システム

★調査レポート[治験管理システムの世界市場予測（～2022年）] ( Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022 / HIT-1686) 販売に関する免責事項
[治験管理システムの世界市場予測（～2022年）] ( Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022 / HIT-1686) についてEメールでお問い合わせ
◆関連調査資料◆
  • 射撃検知システムの世界市場予測（～2022年）
    MAM-AS-3081 / MarketsandMarkets / 2017年2月28日 / 当調査レポートでは、射撃検知システムの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、用途別分析、種類別分析、製品別分析、地域別分析、射撃検知システムの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The gunshot detection system market is projected to grow from USD 726.3 Million in 2016 to USD 3,099.8 Million by 2022, at a CAGR of 27.36% during the forecast period. Factors such as lack of stringent gun-ownership laws and easy availability of guns have resulted in an increase in gun deaths in the U.S. The use of gunshot detection systems in the military has increased due to the rise of terrorism and the need for technological advancements. On the basis of application, the gunshot detection system market has been segmented into homeland and defense. The homeland segment is projected to...
  • スターター飼料の世界市場予測（～2022年）
    MAM-AGI-5047 / MarketsandMarkets / 2017年2月28日 / 当調査レポートでは、スターター飼料の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、成分別分析、家畜別分析、形状別分析、スターター飼料の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The market for starter feed is projected to reach USD 29.15 Billion by 2022, growing at a CAGR of around 4.57% from 2016. The global starter feed market has grown exponentially in the last few years. The need to increase livestock production to cater to the rise in demand for animal-sourced products and the adoption of precision nutrition techniques are the major drivers for the market. On the basis of type, the starter feed market is segmented into medicated and non-medicated. The medicated was the larger segment in 2015. The medicated starter feed segment is also projected to grow at...
  • エピジェネティクスの世界市場予測（～2022年）：キット、酵素、試薬、NGS、質量分析法、PCR、バイオインフォマティクス
    BT-2775 / MarketsandMarkets / 2017年10月12日 / MarketsandMarketsが発行した当調査レポートでは、エピジェネティクスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、用途別分析、技術別分析、需要先別分析、エピジェネティクスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global epigenetics market is projected to reach USD 1,605.7 Million by 2022 from USD 854.0 Million in 2017, at a CAGR of 13.5% during the forecast period. Market growth can be attributed to the decreasing sequencing costs, increase in research activities, availability of funding for epigenetics research, and rising prevalence of cancer. In this report, the global epigenetics market has been segmented on the basis of product, application, technology, end user, and region. Based on product, the global market for epigenetics, is segmented into enzymes, instruments and consumables, kits, reagents, and bioinformatics tools. In 2016, the kits segment accounted...
  • 血液加温器/標本加温器の世界市場予測（～2022年）：血、胚、卵子、精液
    MD-5770 / MarketsandMarkets / 2017年11月28日 / MarketsandMarketsが発行した当調査レポートでは、血液加温器/標本加温器の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、サンプル別分析、需要先別分析、地域別分析、血液加温器/標本加温器の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global blood warmer devices/sample warmers market is expected to reach USD 225.6 Million by 2022 from USD 150.4 Million in 2017, at a CAGR of 8.4%. The increasing burden of hypothermia cases, increasing number of surgeries, and growing number of trauma cases are the key factors driving the growth of this market. The global blood warmer devices market is segmented by sample type, end user, and regions. By sample type, the market is segmented into blood samples and other samples. The blood samples segment is estimated to account for the largest market share of the market in 2017. Factors...
  • バイオシミュレーションの世界市場予測（～2022年）：ソフトウェア、分子シミュレーション、社内、契約サービス
    MAM-HIT-3629 / MarketsandMarkets / 2018年1月3日 / MarketsandMarketsが発行した当調査レポートでは、バイオシミュレーションの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別分析、用途別分析、需要先別分析、地域別分析、バイオシミュレーションの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global biosimulation market is projected to reach USD 2.88 Billion by 2022 from USD 1.38 Billion in 2017, at a CAGR of 15.9%. Factors such as increase in R&D investments in the pharmaceutical and biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery and development costs, and growth in the biologics and biosimilars markets are driving the growth of the market. The report segments the global biosimulation market into by product & service, application, delivery model, end user, and region. Based on product & service, the biosimulation market is...
  • ラベルフリー検出の世界市場予測（～2022年）：技術（表面プラズモン共鳴法、バイオレイヤー干渉法）、製品、用途、エンドユーザー
    BT-2455 / MarketsandMarkets / 2017年10月11日 / MarketsandMarketsが発行した当調査レポートでは、ラベルフリー検出の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別分析、製品別分析、用途別分析、需要先別分析、ラベルフリー検出の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global label-free detection market is expected to reach USD 1,311.2 Million by 2022 from USD 872.0 Million in 2017, at a CAGR of 8.5%. A number of factors such as increasing number of genomics research activities for studying diseases, advances in label-free detection techniques, growing awareness and demand for use of biosensors in biomolecular interaction studies, and increasing expenditure on drug discovery and development by private and public organizations are expected to drive the growth of this market. The global label-free detection market is segmented by product, technology, application, end user, and region. By product, the market is segmented...
  • 解凍装置の世界市場予測（～2022年）：種類、サンプル（血、血漿、RBC、血小板、全血、胎芽、精液）、エンドユーザー
    MD-5756 / MarketsandMarkets / 2017年11月23日 / MarketsandMarketsが発行した当調査レポートでは、解凍装置の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、サンプル別分析、需要先別分析、地域別分析、解凍装置の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global thawing system market is expected to reach USD 252.7 Million by 2022 from USD 139.6 Million in 2017, at a CAGR of 12.6%. The market growth is primarily driven by the growing incidence of chronic diseases and technological advancements in thawing devices. The global thawing system market is segmented by type, sample type, end user, and region. By type, the thawing system market is segmented into manual and automated devices. The manual devices segment is estimated to account for the largest market share of the global thawing system market in 2017. Factors driving the growth of this segment...
  • 3D細胞培養の世界市場予測（～2022年）：足場材フリー（懸滴培養、バイオリアクタ）、マイクロ流体力学、磁気浮上
    MAM-BT-4414 / MarketsandMarkets / 2017年11月8日 / MarketsandMarketsが発行した当調査レポートでは、3D細胞培養の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品種類別分析、用途別分析、需要先別分析、地域別分析、3D細胞培養の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global 3D cell culture market is projected to reach USD 1,720.3 Million by 2022 from USD 682.8 Million in 2017, at a CAGR of 20.3%. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness are driving the growth of the market. The report segments the global market into by type of product, application, end user, and region. Based on product, the market is segmented into scaffold-based 3D cell culture, scaffold-free 3D cell culture, microfluidics-based 3D cell culture, and magnetic levitation and...
  • 分子生物学用酵素・キット・試薬の世界市場予測（～2022年）：PCR、シーケンシング、クローニング、エピジェネティクス
    MAM-BT-2612 / MarketsandMarkets / 2017年10月10日 / MarketsandMarketsが発行した当調査レポートでは、分子生物学用酵素・キット・試薬の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、用途別分析、需要先別分析、地域別分析、分子生物学用酵素・キット・試薬の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global molecular biology enzymes and kits & reagents market is projected to reach USD 13.60 Billion by 2022 from USD 6.52 Billion in 2017, at a CAGR of 15.8% during the forecast period. The growth of this market is majorly driven by factors such as increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of infectious diseases & genetic disorders. The molecular biology enzymes and kits & reagents market is segmented on the basis of product, application, end user, and region. On...
  • 生体機能チップの世界市場予測（～2022年）：種類別（肝臓、腎臓、肺、心臓、腸、消化管）、提供物別（製品、サービス）、用途別（毒性試験、生理学的モデル）、エンドユーザー別（学術、研究機関、製薬会社）
    MAM-BT-5883 / MarketsandMarkets / 2018年1月12日 / MarketsandMarketsが発行した当調査レポートでは、生体機能チップの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、生体機能チップの世界市場規模及び予測、セグメント別市場規模、市場動向、競争状況、関連企業分析などの情報をお届けいたします。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・生体機能チップ市場：種類別 ・生体機能チップ市場：提供物別 ・生体機能チップ市場：用途別 ・生体機能チップ市場：エンドユーザー別...The organs-on-chips market is expected to reach USD 45.6 Million by 2022 from USD 9.6 Million in 2017, at a CAGR of 36.6%. The growth of this market is mainly driven by the growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of organs-on-chips, technological advancements and new products launches, growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers, and growing need for early detection of drug toxicity to minimize financial losses due to late stage drug failure. This report segments the organs-on-chips market into...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆